The association between the cumulative dose of aminoglycoside exposure and hearing loss in children with cystic fibrosis

C. Yegit (Istanbul, Turkey), P. Ergenekon (Istanbul, Turkey), M. Yanaz (Istanbul, Turkey), A. Guliyeva (Istanbul, Turkey), M. Kalyoncu (Istanbul, Turkey), O. Meral (Istanbul, Turkey), M. Selcuk (Istanbul, Turkey), G. Tastan (Istanbul, Turkey), B. Uzunoglu (Istanbul, Turkey), N. Ozturk (Istanbul, Turkey), F. Toktas (Istanbul, Turkey), A. Atas (Istanbul, Turkey), H. Cetin Kara (Istanbul, Turkey), A. Collak (Istanbul, Turkey), N. Bal (Istanbul, Turkey), O. Gedik (Istanbul, Turkey), Y. Oruc (Istanbul, Turkey), M. Acar (Istanbul, Turkey), R. Dogan (Istanbul, Turkey), E. Gozen Tan (Istanbul, Turkey), H. Molla Kafi (Istanbul, Turkey), N. Karasu (Istanbul, Turkey), Y. Ayhan (Istanbul, Turkey), A. Yumusakhuylu (Istanbul, Turkey), A. Kilinc Sakalli (Istanbul, Turkey), E. Cakir (Istanbul, Turkey), S. Girit (Istanbul, Turkey), Y. Gokdemir (Istanbul, Turkey), E. Erdem Eralp (Istanbul, Turkey), P. Ata (Istanbul, Turkey), A. Ciprut (Istanbul, Turkey), F. Karakoc (Istanbul, Turkey), B. Karadag (Istanbul, Turkey)

Source: International Congress 2022 – Cystic fibrosis in children and adolescents

Session: Cystic fibrosis in children and adolescents
Session type: Thematic Poster
Number: 289

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Yegit (Istanbul, Turkey), P. Ergenekon (Istanbul, Turkey), M. Yanaz (Istanbul, Turkey), A. Guliyeva (Istanbul, Turkey), M. Kalyoncu (Istanbul, Turkey), O. Meral (Istanbul, Turkey), M. Selcuk (Istanbul, Turkey), G. Tastan (Istanbul, Turkey), B. Uzunoglu (Istanbul, Turkey), N. Ozturk (Istanbul, Turkey), F. Toktas (Istanbul, Turkey), A. Atas (Istanbul, Turkey), H. Cetin Kara (Istanbul, Turkey), A. Collak (Istanbul, Turkey), N. Bal (Istanbul, Turkey), O. Gedik (Istanbul, Turkey), Y. Oruc (Istanbul, Turkey), M. Acar (Istanbul, Turkey), R. Dogan (Istanbul, Turkey), E. Gozen Tan (Istanbul, Turkey), H. Molla Kafi (Istanbul, Turkey), N. Karasu (Istanbul, Turkey), Y. Ayhan (Istanbul, Turkey), A. Yumusakhuylu (Istanbul, Turkey), A. Kilinc Sakalli (Istanbul, Turkey), E. Cakir (Istanbul, Turkey), S. Girit (Istanbul, Turkey), Y. Gokdemir (Istanbul, Turkey), E. Erdem Eralp (Istanbul, Turkey), P. Ata (Istanbul, Turkey), A. Ciprut (Istanbul, Turkey), F. Karakoc (Istanbul, Turkey), B. Karadag (Istanbul, Turkey). The association between the cumulative dose of aminoglycoside exposure and hearing loss in children with cystic fibrosis. 289

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.